 | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
This is a duplicate page: BIIB033 is Opicinumab. (See http://www.biocentury.com/products/biib033)
Also note the stage II failure of this substance: http://investorplace.com/2016/06/biib-stock-biogen-opicinumab-failure-ms-treatment/